Financial Insights That Matter
LONDON, Feb. 25, 2025 /PRNewswire/ — Contura Orthopedics is pleased to announce the launch of Contura Orthopedics (Canada) Ltd.marking a major milestone in the company’s global expansion. This follows Health Canada’s approval of Arthrosamid® in 2024bringing the availability of this novel hydrogel injection to patients with knee pain caused by osteoarthritis (OA) in North America.
Addressing the Growing Burden of Osteoarthritis
Osteoarthritis is the most common form of arthritis, affecting millions worldwide and imposing a significant burden on healthcare systems. In Canadaapproximately 4 million people[1] suffer from OA, with knee osteoarthritis being a leading cause of pain, mobility issues and reduced quality of life. As the population ages and obesity rates rise, the prevalence of OA continues to grow, increasing the demand for effective, long-term solutions for pain management.
Despite the widespread impact of knee osteoarthritis, pain management options remain limited. Many patients rely on painkillers or corticosteroid injections, which offer only temporary relief, while others face the prospect of invasive knee replacement surgery. Innovation in OA management is crucial to bridging this gap and providing patients with better solutions that improve mobility and long-term joint function.
Introducing a Novel, Long-Lasting[2-3] OA Hydrogel
Arthrosamid® (2.5% iPAAG) is a unique permanent injectable hydrogel[4] designed to provide long-lasting[2-3] pain relief for knee osteoarthritis sufferers. Unlike traditional OA injections, Arthrosamid® integrates into the synovial tissue of the knee,[4] helping to reduce pain with a single-dose, without surgery. Clinical studies have demonstrated sustained pain relief and improved function out to 4 years,3 offering patients an innovative new option in OA care.
A Strategic Expansion and Strong Leadership
To lead our efforts in Canadawe are pleased to welcome Peter Tomashewski as our Canadian Commercial Leader. Peter brings a wealth of experience in the medical device and pharmaceutical industries, with a proven track record of successfully bringing novel therapies to market. His leadership will be instrumental in ensuring that Canadian patients and healthcare professionals have access to Arthrosamid®.
Rakesh TailorCEO of the Contura Group, commented: “The expansion into Canada is a significant step for Contura as we work to make Arthrosamid® available to patients worldwide.
#1a73e8;">Boost Your Financial Knowledge and Achieve Stability
Discover a growing online community dedicated to delivering financial news, tips, and strategies designed to help you manage money effectively, save smarter, and grow your investments with confidence.
#1a73e8;">Top Financial Tips for Saving and Investing
- Personal Finance Management: Master the art of budgeting, expense tracking, and building a strong financial foundation.
- Investment Opportunities: Stay updated on market trends, learn about stocks, and explore secure ways to grow your wealth.
- Expert Money-Saving Advice: Access proven techniques to reduce expenses and maximize your financial potential.